07:00 , Mar 31, 2014 |  BC Week In Review  |  Financial News

RuiYi completes venture financing

RuiYi Inc. , La Jolla, Calif.   Business: Autoimmune, Cancer   Date completed: 3/27/14   Type: Venture financing   Raised: $15 million   Investors: 5AM Ventures; Versant Ventures; Apposite Capital; SR One; MS Ventures; Aravis...
00:50 , Mar 28, 2014 |  BC Extra  |  Financial News

RuiYi raises $15 million in B round

RuiYi Inc. (La Jolla, Calif.) raised $15 million in a series B round from existing investors 5AM Ventures; Versant Ventures; Apposite Capital; SR One; MS Ventures; and Aravis Venture. RuiYi also hired Erik Karrer as...
08:00 , Feb 24, 2014 |  BC Week In Review  |  Financial News

SynAffix completes venture financing

SynAffix B.V. , Oss, the Netherlands   Business: Antibodies, Computational chemistry/biology   Date completed: 2/18/14   Type: Venture financing   Raised: Not disclosed   Investors: Aravis Venture; BioGeneration Ventures; MS Ventures; BOM Capital  ...
08:00 , Dec 9, 2013 |  BC Week In Review  |  Financial News

Telormedix financial update

Telormedix raised CHF6 million ($6.6 million) in an extension of its series B round, bringing the total raised in the round to CHF13.5 million ($14.5 million) Existing investors Aravis Venture and ProQuest Investments participated. The...
07:00 , May 20, 2013 |  BioCentury  |  Finance

Merck Serono's earnest money

Four years after launching a strategic venture fund, the Merck Serono S.A. unit of Merck KGaA is making a long-term commitment with an infusion of €60 million ($77.8 million). While the fund's focus will remain...
08:00 , Jan 16, 2012 |  BC Week In Review  |  Financial News

Telormedix completes venture financing

Telormedix S.A. , Bioggio, Switzerland   Business: Cancer   Date completed: 1/10/12   Type: Venture financing   Raised: CHF7.5 million ($7.9 million)   Investors: Aravis Venture; ProQuest Investments  ...
07:00 , Oct 18, 2010 |  BC Week In Review  |  Financial News

Synosia completes venture financing

Synosia Therapeutics AG , Basel, Switzerland   Business: Neurology   Date completed: 10/12/10   Type: Venture financing   Raised: $30 million   Investors: UCB Group ; Versant Ventures; 5AM Ventures; Novo A/S; Aravis Venture; Investor...
07:00 , Oct 18, 2010 |  BioCentury  |  Finance

Synosia's POC

Synosia Therapeutics S.A. was rewarded by investors last week with a new round of financing - potentially its last before an exit - as it also announced its first out-licensing deal for two Parkinson's disease...
23:57 , Oct 12, 2010 |  BC Extra  |  Company News

Synosia raises $30M, partners with UCB

Synosia Therapeutics AG (Basel, Switzerland) raised $30 million in a series C round and granted UCB Group (Euronext:UCB) exclusive, worldwide rights to two Parkinson's disease (PD) candidates. SYN-115 , an oral adenosine A2A receptor (ADORA2A)...
07:00 , Jul 19, 2010 |  BC Week In Review  |  Financial News

MerLion completes venture financing

MerLion Pharmaceuticals Pte. Ltd. , Singapore   Business: High throughput screening   Date completed: 7/13/10   Type: Venture financing   Raised: $7 million   Investors: Aravis Venture; Aurelia Private Equity GmbH; Bio*One Capital; Heidelberg Innovation;...